Atlas Trials

Effect of RBT-1 on Preconditioning Response Biomarkers in Subjects Undergoing CABG and/or Cardiac Valve Surgery

Clinical trial NCT04564833 · COMPLETED

Trial details

NCT number
NCT04564833
Sponsor
Renibus Therapeutics, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
AKI
Start date
2021-08-04
Primary completion
2022-11-09
Enrollment
152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.